Director, Global Value & Access Strategy (Cell-Therapy Autoimmune)

Gilead Sciences•Foster City, CA

1d•$205,615 - $292,710•Hybrid

About The Position

We are seeking a Director, Global Value & Access Strategy (GVAS), Cell-therapy Autoimmune. This role reports to the Senior Director, GVA Lead, Lymphoma, Autoimmune and Solid Tumors/Pipeline. This role will be office-based/hybrid (3 days onsite) in El Segundo or Thousand Oaks or Foster City, CA. In this position, you will be a critical Global Value & Access partner for Kite's growing autoimmune cell therapy portfolio. You will lead the development and execution of global market access strategies to support early and late-stage development programs, while preparing for future launches of transformative cell therapies across autoimmune diseases. You will work closely with Global Clinical Development, Medical Affairs, HEOR/RWE, Commercial, Regulatory Affairs and regional Access teams to ensure payer perspectives are incorporated into development decisions and launch planning. You will play a key role in shaping evidence generation strategies that support differentiated value propositions, reimbursement, and patient access across major global markets.

Requirements

8+ years with a PhD/ PharmD
OR 10+ years with MS/MA, MBA, PharmD, PhD or equivalent advanced degree
OR 12+ years with BS/BA

Nice To Haves

3+ years of direct experience supporting autoimmune disease programs, including development-stage assets, clinical strategy, market access, medical affairs, commercial strategy, or related functions.
Deep understanding of autoimmune disease treatment paradigms, competitive dynamics, and unmet patient needs.
Experience in advanced therapies, including cell therapy and/or gene therapy, strongly preferred.
Experience supporting market access, pricing, reimbursement, HEOR, commercial strategy, or related functions within the pharmaceutical or biotechnology industry.
Experience supporting early and/or late-stage development programs and translating payer insights into development decisions.
Demonstrated experience incorporating payer, HTA, and health system requirements into clinical development and evidence generation strategies.
Experience supporting launch readiness activities, global launch planning, and lifecycle management.
Strong understanding of global payer, pricing, reimbursement, and HTA landscapes.
Experience partnering with HEOR, RWE, Medical Affairs, Clinical Development, and Commercial functions to develop value evidence strategies.
Understanding of value frameworks, reimbursement pathways, and evidence requirements across major global markets.
Demonstrated ability to influence cross-functional teams in a matrix environment.
Strong strategic thinking, analytical, and problem-solving skills.
Excellent communication skills and experience presenting to senior leadership.
Proven ability to collaborate across functions, regions, cultures, and time zones.
Ability to thrive in a fast-paced environment characterized by innovation and portfolio growth.

Responsibilities

Serve as the Global Market Access representative for assigned autoimmune programs and contribute to cross-functional conversations.
In the Value Access Sub-Team, you will be leading and partnering with the Global and Regional functions of Value Access, HEOR/RWE and commercial to ensure efficient integration of Access input into the Portfolio Strategy.
Lead the development of global value and access strategies across the product lifecycle, from early development through launch and lifecycle management.
Ensure payer, HTA, and health system perspectives are reflected in development, evidence generation, pricing, and commercialization strategies.
Partner with regional and country access teams to develop integrated global-to-local reimbursement strategies.
Analyze market access trends, evolving reimbursement requirements, competitive dynamics, and health system considerations across major markets including the US, EU5, Canada, Australia, and Japan.
Provide market access input into target product profiles, clinical development plans, endpoint selection, comparator strategy, study design, and evidence generation plans.
Advise development teams on evidence requirements needed to support future reimbursement, pricing, and formulary access decisions.
Ensure access-relevant considerations are incorporated into development milestones and governance decisions.
Partner with Clinical, HEOR, RWE and Medical Affairs to develop and execute early payer engagement and HTA scientific advice strategies across multiple autoimmune indications, ensuring payer perspectives are incorporated into evidence generation and development plans.
Provide strategic leadership on US market access dynamics across autoimmune indications, including payer formulary management, utilization management (e.g., step edits and prior authorization), and rebate contracting strategies, ensuring these considerations are proactively incorporated into development, evidence generation, pricing, and launch planning.
Lead cross-functional assessment of payer, HTA, and health system evidence requirements across key global markets, translating insights into actionable recommendations for clinical development programs.
Assess the access implications of development opportunities across autoimmune indications and advise governance teams on the likelihood of achieving favorable pricing, reimbursement, and patient access outcomes.
Partner with HEOR, RWE, Medical Affairs, and Commercial teams to develop compelling value propositions and evidence packages.
Advise on the development of economic models, burden-of-illness studies, indirect treatment comparisons, and other payer-focused evidence.
Act as the market access lead within cross-functional teams, ensuring alignment across Development, Medical Affairs, Commercial, Regulatory Affairs, Pricing, and HEOR.
Influence strategic decisions through robust assessment of payer expectations, reimbursement risks, and value opportunities.
Create Inclusion: Know the business value of diverse teams, model inclusive leadership, and foster an environment where diversity and belonging drive innovation and performance.
Develop Talent: Understand the skills, experiences, aspirations, and potential of employees and provide coaching and development opportunities to help them grow and achieve their career goals.
Empower Teams: Align teams to organizational priorities, remove barriers, encourage accountability, and create an environment where individuals can do their best work.